An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer - Concepedia

Concepedia

Publication | Closed Access

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

108

Citations

27

References

2021

Year

Thomas Powles, Danielle Carroll, Simon Chowdhury, Gwénaëlle Gravis, Florence Joly, Joan Carles, Aude Fléchon, Pablo Maroto, Daniel P. Petrylak, Frédéric Rolland,

Nature Medicine

UrologyNovel TherapyGenitourinary CancerMedicineBiomarker TargetImmune Checkpoint InhibitorAdvanced Urothelial CancerTargeted TherapiesBiomarker-directed Platform StudyCancer TreatmentOncologyRadiation OncologyTumor Microenvironment

References

	Year	Citations

Page 1

Page 1